Avidity Biosciences, Inc. (RNA)
USD 30.7
(-6.23%)
USD 30.7
(-6.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -119.06 Million | -136.26 Million | -94.81 Million | -37.11 Million | 2.49 Million | -9.65 Million |
| Net Income | -212.22 Million | -173.99 Million | -118 Million | -44.35 Million | -24.73 Million | -11.21 Million |
| Depreciation & Amortization | 2.1 Million | 1.38 Million | 639 Thousand | 373 Thousand | 348 Thousand | 383 Thousand |
| Deferred income taxes | -1.76 Million | - | - | 84 Thousand | - | - |
| Stock-based compensation | 38.22 Million | 27.13 Million | 17.05 Million | 4.31 Million | 406 Thousand | 60 Thousand |
| Change in working capital | 61.12 Million | 9.81 Million | 5.33 Million | 2.33 Million | 19.12 Million | 671 Thousand |
| Other non-cash items | -6.52 Million | -615 Thousand | 163 Thousand | 139 Thousand | 7.34 Million | 447 Thousand |
| Investing Cash Flow | -130.07 Million | -189.95 Million | -82.51 Million | -7.78 Million | -235 Thousand | -49 Thousand |
| Investments in PPE | -4.22 Million | -2.82 Million | -3.74 Million | -1.09 Million | -235 Thousand | -49 Thousand |
| Acquisitions | 125.84 Million | 187.13 Million | 82.51 Million | - | - | - |
| Investment purchases | -461 Million | -355.83 Million | -85.35 Million | -6.69 Million | - | - |
| Sales/Maturities of investments | 335.16 Million | 168.7 Million | 6.58 Million | - | - | - |
| Other Investing Activities | -125.84 Million | -187.13 Million | -82.51 Million | -6.69 Million | - | - |
| Financing Cash Flow | 93.86 Million | 346.17 Million | 176.31 Million | 272.03 Million | 89.23 Million | 5.14 Million |
| Debt repayment | - | - | - | -4.68 Million | -2.8 Million | -4.98 Million |
| Dividends payments | - | - | - | - | -106 Thousand | - |
| Common Stock Repurchased | - | - | - | 444 Thousand | - | - |
| Common Stock Issuance | 93.86 Million | 344.77 Million | 176.31 Million | 276.72 Million | 65 Thousand | 162 Thousand |
| Other Financing Activities | 33.31 Million | 1.39 Million | 176.31 Million | 276.72 Million | 92.07 Million | 162 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.76 Million | 18.31 Million | 6.04 Million | 5.74 Million | 451 Thousand | 780 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 59.36 Million | -8.49 Million | -705 Thousand | -3.41 Million | 18.67 Million | 671 Thousand |
| Cash at beginning of period | 340.39 Million | 320.69 Million | 321.71 Million | 94.57 Million | 3.09 Million | 7.65 Million |
| Cash at end of period | 185.08 Million | 340.64 Million | 320.69 Million | 321.71 Million | 94.57 Million | 3.09 Million |
| Capital Expenditure | -4.22 Million | -2.82 Million | -3.74 Million | -1.09 Million | -235 Thousand | -49 Thousand |
| Effect of forex changes on cash | -44 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -155.31 Million | 19.94 Million | -1.01 Million | 227.13 Million | 91.48 Million | -4.56 Million |
| Free Cash Flow | -123.29 Million | -139.09 Million | -98.55 Million | -38.2 Million | 2.25 Million | -9.7 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -70.79 Million | -68.85 Million | -212.22 Million | -60.44 Million | -52.35 Million | -47.02 Million |
| Depreciation & Amortization | 687 Thousand | 641 Thousand | 2.1 Million | 615 Thousand | 566 Thousand | 529 Thousand |
| Deferred income taxes | - | - | -1.76 Million | -8.71 Million | -2.96 Million | -2.84 Million |
| Stock-based compensation | 12.81 Million | 10.3 Million | 38.22 Million | 9.84 Million | 9.82 Million | 9.45 Million |
| Change in working capital | -4.05 Million | -10.34 Million | 61.12 Million | 68.89 Million | 7.41 Million | -10.65 Million |
| Other non-cash items | 7.06 Million | 6.88 Million | -6.52 Million | 6.3 Million | 734 Thousand | 732 Thousand |
| Investing Cash Flow | -274.86 Million | -32.74 Million | -130.07 Million | 51.04 Million | -31.47 Million | 46.04 Million |
| Investments in PPE | -531 Thousand | -915 Thousand | -4.22 Million | -863 Thousand | -923 Thousand | -622 Thousand |
| Acquisitions | - | - | 125.84 Million | -51.9 Million | 30.55 Million | -46.67 Million |
| Investment purchases | -372.54 Million | -141.55 Million | -461 Million | -53.8 Million | -131.79 Million | -24.05 Million |
| Sales/Maturities of investments | 98.2 Million | 109.72 Million | 335.16 Million | 105.71 Million | 101.23 Million | 70.72 Million |
| Other Investing Activities | - | -31.83 Million | -125.84 Million | 51.9 Million | -30.55 Million | 46.67 Million |
| Financing Cash Flow | 446.72 Million | 389.44 Million | 93.86 Million | 31.89 Million | 40 Thousand | 38.97 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 446.72 Million | 389.44 Million | 93.86 Million | 31.89 Million | 40 Thousand | 38.1 Million |
| Other Financing Activities | 13.67 Million | 389.44 Million | 33.31 Million | 31.89 Million | 40 Thousand | 866 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 3.47 Million | 2.57 Million | 1.76 Million | 2.35 Million | 228 Thousand | -1.97 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -7.53 Million | -12.91 Million | 59.36 Million | 66.54 Million | 7.18 Million | -8.68 Million |
| Cash at beginning of period | 471.4 Million | 185.08 Million | 340.39 Million | 85.65 Million | 154.17 Million | 118.96 Million |
| Cash at end of period | 575.75 Million | 471.4 Million | 185.08 Million | 185.08 Million | 85.94 Million | 154.17 Million |
| Capital Expenditure | -531 Thousand | -915 Thousand | -4.22 Million | -863 Thousand | -923 Thousand | -622 Thousand |
| Effect of forex changes on cash | - | - | -44 Thousand | - | - | - |
| Net cash flow / Change in cash | 104.35 Million | 286.31 Million | -155.31 Million | 99.43 Million | -68.23 Million | 35.21 Million |
| Free Cash Flow | -65.53 Million | -71.29 Million | -123.29 Million | 15.63 Million | -37.71 Million | -50.42 Million |
002152
IVT
EAM
603693
HEINY
MSRM